Secrets Of Wdw

When the FDA issued its second Actos bladder cancer safety notice this past summer, millions of Actos users took note. Actos is the popular, previously top-selling Type 2 diabetes medication. At its peak, less than two years ago, Actos was being used by nearly 2.5 million diabetics to control their blood sugar. This past summer, however, events appeared to be spiraling out of control for Actos. For years there have been concerns that Actos may increase the risk of bladder cancer, but multiple medical studies released this year all seem to confirm that Actos bladder cancer concerns are very real. With the primary US Actos study to continue for several more years, the future seems quite uncertain for those who have used Actos for longer than a year, the time the FDA Actos bladder cancer warning stated that someone needed to use Actos to increase the risk of developing bladder cancer. One question many have is when was the risk of Actos bladder cancer first known? Some of the first Actos bladder cancer lawsuits point to a study done by the drug’s manufacturer even before it was tested on people, which demonstrated a higher rate of bladder cancer in laboratory rats and mice. Since that time there has been additional human testing that all seems to show a link between Actos use and higher risks of bladder cancer. While the FDA continues the review the results provided by the drug’s manufacturer, Actos has been suspended from the market in some European countries. If this follows the usual course in the United States, the matter will ultimately be settled more by Actos bladder cancer lawsuits then the FDA’s intervention.